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ABSTRACT 29 
Binding of HIV-1 and SIV gp120 exterior envelope glycoprotein to CD4 triggers 30 
conformational changes in gp120 that promote its interaction with one of the chemokine 31 
receptors, usually CCR5, ultimately leading to gp41-mediated virus-cell membrane 32 
fusion and entry. We previously described that topological Layers (Layer 1, Layer 2 and 33 
Layer 3) in the gp120 inner domain contribute to gp120-trimer association in the 34 
unliganded state but also help secure CD4 binding. Relative to Layer 1 of HIV-1 gp120, 35 
the SIVmac239 gp120 Layer 1 plays a more prominent role in maintaining gp120-trimer 36 
association but is minimally involved in promoting CD4 binding, which could be 37 
explained by the existence of a well-conserved Tryptophan 375 (Trp 375) in HIV-38 
2/SIVsmm. Here we investigated the role of SIV Layer 3 on viral entry, cell-to-cell fusion 39 
and CD4 binding.  We observed that a network of interactions involving some residues 40 
of the β8-α5 region in SIVmac239 Layer 3 may contribute to CD4 binding by helping 41 
shape the nearby Phe 43 cavity which directly contacts CD4. In summary, our results 42 
suggest that SIV Layer 3 has a greater impact on CD4 binding than in HIV-1. This work 43 
defines lineage-specific differences in Layer 3 from HIV-1 and SIV. 44 
 45 
IMPORTANCE 46 
CD4-induced conformational changes in the gp120 inner domain involve 47 
rearrangements between three topological layers. While the role of Layers 1-3 for HIV-1 48 
and 1-2 for SIV on gp120 transition to the CD4-bound conformation has been reported, 49 
the role of SIV Layer 3 remains unknown. Here we report that SIV Layer 3 has a greater 50 
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impact on CD4 binding than in HIV-1 gp120. This work defines lineage specific 51 
differences in Layer 3 from HIV-1 and SIV. 52 
53 
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 4
INTRODUCTION 54 
Binding of HIV-1 and SIV gp120 exterior envelope glycoprotein to the initial receptor, 55 
CD4 (1, 2), triggers conformational changes in gp120 that promote its interaction with 56 
one of the chemokine receptors, usually CCR5 (3-10), ultimately leading to gp41-57 
mediated virus-cell membrane fusion and entry (11-14).  We recently described that 58 
topological layers in the gp120 inner domain contribute to gp120-trimer association in 59 
the unliganded state and to secure CD4 binding (15). Indeed, the transition of gp120 60 
from the unbound to the CD4-bound conformation is modulated by the inner domain 61 
Layers 1-3.  While HIV-1 Layers 1 and 2 are required to keep CD4 in place by 62 
decreasing the off-rate of the gp120-CD4 interaction (15), Layer 3 is implicated in the 63 
initial contact and modulates the on-rate of this association (16).  Interestingly, lineage-64 
specific differences on the role of Layer 1 and 2 regarding their contribution to gp120-65 
trimer association and CD4 binding were recently described (17).  Relative to Layer 1 of 66 
HIV-1 gp120, the SIVmac239 gp120 Layer 1 plays a more prominent role in maintaining 67 
gp120-trimer association and is minimally involved in promoting CD4 binding (17).  HIV-68 
2/SIVsmm gp120 glycoproteins, like those of most monkey SIVs, typically have a 69 
tryptophan residue at position 375 (18).  In HIV-1, substitution of tryptophan for serine 70 
375 (S375W), which is well-conserved in the major group of HIV-1, results in the 71 
spontaneous sampling of a conformation closer to CD4-bound state (19).  Residue 375 72 
is located in what is known as the Phe 43 cavity, where Phe 43 of CD4 makes 73 
numerous contacts with conserved gp120 residues critical for CD4 binding (20).  Some 74 
gp120 residues that border this cavity contribute to an aromatic array that helps stabilize 75 
the CD4-bound conformation (15, 20, 21).  Therefore it is possible that relative to HIV-1 76 
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 5
gp120, the HIV-2/SIVsmm gp120 glycoproteins, by virtue of the Phe 43 cavity-filling Trp 77 
375, might naturally exhibit a greater propensity to sample the CD4-bound conformation 78 
explaining a decreased requirement for Layers 1 and 2 in CD4 binding.  However, how 79 
the presence of a tryptophan at position 375 affects the functional role of SIVmac239 80 
gp120 Layer 3, previously shown to play a predominant role in securing CD4 binding in 81 
HIV-1 gp120, is unknown.  Here, we characterize the importance of this element to 82 
SIVmac239 Env integrity and to the process of viral entry, and investigate its role in the 83 
transition to the CD4-bound conformation.   84 
 85 
 86 
87 
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 6
MATERIALS AND METHODS 88 
Modeling full-length SIV gp120.  89 
Modeling of the full-length SIVmac239 gp120 was done by using the X-ray crystal 90 
structure (PDB identifier 3JWD) of the ternary complex consisting of an HIV-1HXBc2 91 
gp120 core with intact N and C termini, two-domain CD4, and the antigen-binding 92 
fragment of the human antibody 48d (21) as a template. Modeling was performed on the 93 
Discovery Studio software platform (Accelrys Software, Inc.). SIVmac239 gp120 94 
glycoprotein modeling was based on protein sequence alignment with full-length HIV-95 
1HXBc2 gp120, using the Modeler (version 9) program in the Accelrys software 96 
package. The gp120 V4 variable loop, consisting of the sequence WSTEGSNNT, was 97 
disordered in the X-ray crystal structure (21) and was added by modeling. 98 
 99 
Cell lines.  100 
293T human embryonic kidney, Cf2Th canine thymocytes (American Type Culture 101 
Collection) and TZM-bl cell lines (NIH AIDS Research and Reference Reagent 102 
Program) were grown at 37°C and 5% CO2 in Dulbecco’s modified Eagle’s medium 103 
(Invitrogen) containing 10% fetal bovine serum (Sigma) and 100 μg/ml of penicillin-104 
streptomycin (Mediatech). Cf2Th cells stably expressing human CD4 and CCR5 105 
(Cf2Th-CD4-CCR5) (22) were grown in medium supplemented with 0.4 mg/ml of G418 106 
(Invitrogen) and 0.15 mg/ml of hygromycin B (Roche Diagnostics). Cf2Th-CCR5 cells 107 
were grown in medium supplemented with 0.4 mg/ml of G418 (Invitrogen). The TZM-bl 108 
cell line is a HeLa cell line stably expressing high levels of CD4 and CCR5 and 109 
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 7
possessing an integrated copy of the luciferase gene under the control of the HIV-1 long 110 
terminal repeat (23). 111 
 112 
Site-directed mutagenesis.  113 
Mutations were introduced individually into the previously described vector expressing 114 
the SIVmac239 envelope glycoproteins (pSIVmac239) (24, 25). Site-directed 115 
mutagenesis was performed using the QuikChange II XL site-directed mutagenesis 116 
protocol (Stratagene). The presence of the desired mutations was determined by 117 
automated DNA sequencing. The numbering of the SIVmac239 and HIV-1 envelope 118 
glycoprotein amino acid residues is based on that of the prototypic HXBc2 strain of HIV-119 
1, where 1 is the initial methionine. 120 
 121 
Immunoprecipitation and CCR5 binding of envelope glycoproteins.  122 
For pulse-labeling experiments, 3×105 293T cells were cotransfected by the calcium phosphate 123 
method with pLTR-Tat and the pSIVmac239 vector expressing the SIVmac239 envelope 124 
glycoproteins. One day after transfection, cells were metabolically labeled for 16 h with 100 125 
μCi/ml [35S]methionine-cysteine ( [35S] protein labeling mix; Perkin-Elmer) in Dulbecco’s 126 
modified Eagle’s medium lacking methionine and cysteine and supplemented with 5% dialyzed 127 
fetal bovine serum. Cells were subsequently lysed in RIPA buffer (140 mM NaCl, 8 mM 128 
Na2HPO4, 2 mM NaH2PO4, 1% NP-40, and 0.05% sodium dodecyl sulfate [SDS]). 129 
Precipitation of radiolabeled SIVmac239 envelope glycoproteins from cell lysates or medium 130 
was performed with a mixture of sera from SIV-infected macaques.   The association index is a 131 
measure of the ability of the mutant gp120 molecule to remain associated with the Env trimer 132 
complex on the expressing cell, relative to that of the wild-type Env trimer.  The association 133 
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 8
index is calculated as follows:  association index = ([mutant gp120]cell × [wild-type 134 
gp120]supernatant)/ ([mutant gp120]supernatant × [wild-type gp120]cell).  The processing index is a 135 
measure of the conversion of the mutant gp160 Env precursor to mature gp120, relative to that 136 
of the wild-type Env trimer.  The processing index was calculated by the formula: processing 137 
index = ([total gp120]mutant × [gp160]wild-type)/ ([gp160]mutant × [total gp120]wild-type).   138 
Alternatively, medium containing radiolabeled envelope proteins was 139 
immunoprecipitated with CD4-Ig for 1 h at 37°C in the presence of 50 μl of 10% protein 140 
A-Sepharose (Amersham Biosciences). Of note, while some differences between 141 
human and rhesus CD4/CCR5 have been reported (24, 26, 27)  we decided to use both 142 
human CD4-Ig and cells expressing human CCR5 to be consistent with previous reports 143 
characterizing the HIV and SIV gp120 inner domain layers  (15, 16). For CCR5 binding, 144 
normalized amounts of radiolabeled SIVmac239 gp120 envelope glycoproteins were 145 
incubated in the presence or absence of 200 nm of sCD4 for 1 h at 37°C. Subsequently, 146 
2 × 106 Cf2Th-CCR5 cells were added for an additional 1 h at 37°C and washed twice 147 
with phosphate-buffered saline (PBS) prior to cell lysis in RIPA buffer. Cell lysates were 148 
immunoprecipitated with a mixture of sera from SIV-infected macaques. All samples 149 
were loaded on polyacrylamide gels and analyzed by autoradiography and by using a 150 
PhosphorImager (Molecular Dynamics).  151 
 152 
Recombinant luciferase viruses.  153 
Recombinant viruses containing the firefly luciferase gene were produced by calcium 154 
phosphate transfection of 293T cells with the HIV-1 proviral vector pNL4.3 Env- Luc and 155 
the plasmid expressing the wild-type or mutant SIVmac239 envelope glycoproteins at a 156 
ratio of 2:1. Two days after transfection, the cell supernatants were harvested; the 157 
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 9
reverse transcriptase activities of all viruses were measured as described previously 158 
(28). The virus-containing supernatants were stored in aliquots at －80°C.  159 
 160 
Infection by single-round luciferase viruses.  161 
Cf2Th-CD4-CCR5 target cells were seeded at a density of 5×103 cells/well in 96-well 162 
luminometer- compatible tissue culture plates (Dynex) 24 h before infection. 163 
Recombinant viruses (10,000 reverse transcriptase units) in a final volume of 100 μl 164 
were then added to the target cells, followed by incubation for 48 h at 37°C; the medium 165 
was then removed from each well, and the cells were lysed by the addition of 30 μl of 166 
passive lysis buffer (Promega) and three freeze-thaw cycles. A microplate luminometer 167 
was used to measure the luciferase activity of each well after the addition of 100 μl of 168 
luciferin buffer (15 mM MgSO4, 15 mMKPO4 [pH 7.8], 1 mM ATP, and 169 
1mMdithiothreitol) and 50 μl of 1mMD-luciferin potassium salt (BD Pharmingen). 170 
 171 
Cell-cell fusion.  172 
To assess cell-to-cell fusion, 3 × 105 293T cells were cotransfected by the calcium 173 
phosphate method with an HIV-1 Tat-expressing plasmid, pLTR-Tat, and the 174 
pSIVmac239 vector expressing the SIVmac239 envelope glycoproteins. Two days after 175 
transfection, 3 × 104 293T cells were added to TZM-bl target cells that were seeded at a 176 
density of 3 × 104 cells/well in 96-well luminometer-compatible tissue culture plates 24 h 177 
before the assay. Cells were co-incubated for 6 h at 37°C, after which they were lysed 178 
by the addition of 30 μl of passive lysisbuffer (Promega) and three freeze-thaw cycles. 179 
Luciferase activity in each well was measured as described above. 180 
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 10
 181 
Purification of recombinant SIVmac239 gp120 glycoproteins 182 
FreeStyle 293F cells (Invitrogen) were grown in FreeStyle 293F medium (Invitrogen) to 183 
a density of 1 x 106 cells/ml at 37°C with 8% CO2 with regular agitation (125 rpm).  Cells 184 
were transfected with a codon-optimized plasmid expressing His6-tagged wild-type or 185 
mutant SIVmac239 gp120 using the 293Fectin reagent, as directed by the manufacturer 186 
(Invitrogen).  One week later, the cells were pelleted and discarded.  The supernatants 187 
were filtered (0.22-μ filter) (Corning) and the gp120 glycoproteins were purified by nickel 188 
affinity columns, as directed by the manufacturer (Invitrogen) followed by FPLC 189 
purification of monomeric gp120, as described (29).  The gp120 preparations were 190 
dialyzed against PBS and stored in aliquots at -80°C.  To assess purity, recombinant 191 
proteins were loaded on SDS-PAGE polyacrylamide gels and stained with Coomassie 192 
Blue. 193 
 194 
SPR biosensor analysis.  195 
Surface plasmon resonance (SPR) biosensor data were collected on a Biacore 3000 196 
optical biosensor (General Electric). CD4-Ig was immobilized onto separate flow cells 197 
within the same sensor chip (CM5; GE) to a surface density of around 500 response 198 
units (RU) using standard amine coupling chemistry (30). The binding capacities of CD4 199 
surfaces were kept low to avoid mass transport effects and steric hindrance. Flow cell 1 200 
or 3 was left blank as a control for nonspecific binding and refractive index changes. 201 
With the instrument operating in a parallel sensing mode, soluble gp120 was injected 202 
over flow cells 1 and 2 or 3 and 4 at different concentrations ranging from 100 to 750 203 
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nM at a flow rate of 30 μl/min for 3 min. This was followed by a 10-min dissociation 204 
phase to allow an estimation of off-rates and binding affinities. Sensor data were 205 
prepared for kinetic analysis by subtracting binding responses collected from the blank 206 
reference surface. The association and dissociation phase data were fitted 207 
simultaneously with BIAevalution, version 3.2, RC1 software using a 1:1 Langmuir 208 
model of binding. 209 
 210 
211 
 o
n
 August 17, 2016 by UNIV O
F NEBRASKA-LINCO
LN
http://jvi.asm.org/
D
ow
nloaded from
 
 12
RESULTS 212 
The SIVmac239 gp120 layer 3 inner domain mutants 213 
The nine intra-chain disulfide bonds in HIV-1 gp120 glycoproteins are conserved in all 214 
primate immunodeficiency virus gp120 glycoproteins, assisting the alignment of the 215 
HIV-1 and SIVmac239 gp120 sequences (18, 31).  To evaluate the functional role of 216 
SIV gp120 Layer 3 and how it compares with HIV-1, the SIVmac239 gp120 Layer 3 and 217 
Phe 43 cavity primary amino acid sequence was aligned with that of HIV-1 group M and 218 
HIV-2 gp120 (Figure 1A).  Five Layer 3 residues (247, 248, 480, 482 and 483) were 219 
identical and only the nature of two others, 251 and 479, was preserved (Figure 1A).  220 
Comparison of the Phe 43 cavity sequences indicates that HIV-2 and SIVmac have a 221 
large residue (Trp) at position 375 that likely fills the Phe 43 cavity (18) (Figure 1A) 222 
whereas HIV-1 has an “empty” Phe 43 cavity by virtue of its smaller residue (a serine) at 223 
this position.  Altogether, these results suggest that substantial differences exist 224 
between the inner domain Layer 3 of HIV-1 and SIVmac239/HIV-2 gp120. We 225 
introduced point mutations in residues 248 to 254 and 476 to 483 of SIVmac239 and 226 
evaluated the ability of the variants to interact with the receptor CD4 and coreceptor 227 
CCR5, we also evaluated their ability to mediate viral infectivity, cell-to-cell fusion and 228 
their contribution to trimer stability (association index) and processing of the gp160 229 
precursor (processing index) (Table 1). 230 
 231 
Proteolytic processing and subunit association of SIVmac239 variants 232 
Proteolytic processing of the gp160 precursor and association of the gp120 and gp41 233 
subunits of each SIVmac239 Env variant were evaluated by transfecting 293T followed 234 
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 13
by radiolabelling and immunoprecipitation of cell lysates and supernatant with polyclonal 235 
sera from SIV-infected macaques. All of the mutants were expressed efficiently and only 236 
mutants T248A, R249A, L481A and L483A exhibited a marked decrease in proteolytic 237 
processing of the gp160 Env precursor (Table 1) (Figure 2A).  A similar phenotype was 238 
previously observed for T248A in HIV-1 gp120, perhaps due to its proximity to cysteine 239 
247 which might be important for Env folding. While in HIV-1 gp120 only changes in 240 
residue W479 significantly disrupted the non-covalent association of gp120 with the Env 241 
trimer (16), in SIVmac239 changes in residues 478-481 affected trimer stability below 242 
half of their wild-type counterpart (Table 1, Figure 2B and Figure 5A). Similar to the 243 
unique position of W479 in HIV-1 gp120, residues 478-481 of SIVmac239 are located at 244 
the center of a hydrophobic interface between Layers 2 and 3 (Figure 1 D and E) and 245 
their mutation might affect trimer stability through effects on Layer 2-Layer 3 246 
association, which could indirectly affect gp120-trimer association by altering either the 247 
gp120 trimer association domain or the gp120-gp41 interface.    248 
 249 
Function of the mutant SIV envelope glycoproteins 250 
We next evaluated the effect of alteration of Layer 3 residues on the ability of 251 
SIVmac239 Env to mediate viral infectivity (Figure 3A) and cell-to-cell fusion (Figure 252 
3B). In striking contrast with what we reported for HIV-1 gp120 Layer 3 mutants where 253 
only W479 presented a significant decrease in viral infectivity (16), we observed that the 254 
majority of SIVmac239 gp120 Layer 3 changes (T248A, R249A, E477A, L478A, Y479A, 255 
R480A, L481A, E482A, L483A) impacted viral infectivity below 20% of the wild-type.  256 
However, all the variants mediated cell-to-cell fusion much more efficiently than cell-free 257 
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virus infection. This phenotype has previously been observed for alterations in the inner 258 
domain Layers 1 and 2 and the β-sandwich that effect gp120-trimer association (15, 259 
32).  While a defect in processing (T248A, R249A, R480A, L481A, L483A) and trimer 260 
stability (L478A, Y479A, R480A and L481A) could explain part of the major impairment 261 
to mediate viral infectivity, these parameters did not account for the marked loss of 262 
infectivity of E477A and E482A, suggesting that additional mechanisms could account 263 
for their impaired ability to mediate viral infection.   264 
 265 
Interaction of the mutant SIVmac239 envelope glycoproteins with CD4 and CCR5 266 
Alteration of the interface between Layers 1 and 2 of the HIV-1 gp120 inner domain has 267 
been shown to decrease CD4 binding, revealing an important mechanism whereby HIV-268 
1 gp120 regulates CD4-induced conformational rearrangement and achieves a 269 
reduction in off-rate (15, 21, 33).  To investigate the contribution of Layer 3 of SIV gp120 270 
to CD4 binding, the CD4-binding ability of the panel of SIVmac239 Layer 3 gp120 271 
mutants was examined.  Wild-type and mutant SIVmac239 envelope glycoproteins were 272 
transiently expressed in 293T cells, which were radiolabeled for 16 h.  The amount of 273 
radiolabeled gp120 glycoproteins shed into the cell medium was normalized by 274 
immunoprecipitation with polyclonal serum from SIV-infected macaques before 275 
assessing the ability to bind CD4-Ig. As shown in Table 1 and Figure 4A, a major defect 276 
on CD4 binding was observed for the majority of SIV239 Layer 3 variants, in agreement 277 
with a critical role of Layer 3 in CD4 interaction.  Indeed, with the exception of Q254A 278 
and A476G, the rest of the mutants (248-253 and 477-483) bound CD4-Ig below 40% of 279 
their wild-type counterpart (Figure 4A and Figure 5B).  As previously shown for HIV-1 280 
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gp120 Layer 3 variants, the observed decreases in CD4 binding were mainly due to 281 
decreased on-rates (A476G, E477A, Y479A and E482A) compared with that of WT 282 
gp120 except for T248A (Table 1).  Thus, gp120 mutants with alterations in Layer 3 fail 283 
to engage CD4 efficiently.  Therefore, multiple residues in Layer 3 of the gp120 inner 284 
domain that, based on our modeling, do not directly contact CD4 nonetheless contribute 285 
to the affinity of the gp120-CD4 interaction. A network of interactions involving some 286 
residues of the β8-α5 region in Layer 3 may contribute to CD4 binding by helping shape 287 
the nearby Phe 43 cavity that directly contacts CD4 (20, 34, 35).  288 
 289 
The functional consequence of CD4 binding for HIV-1 and SIV envelope 290 
glycoproteins is the interaction with co-receptor CCR5 or CXCR4 (3-10).  We analyzed 291 
whether introducing changes in Layer 3 of the SIVmac239 gp120 inner domain affected 292 
CCR5 recognition.  Radiolabeled wild-type and mutant SIV gp120 glycoproteins were 293 
incubated in the presence or absence of sCD4 for 1 h at 37 ºC prior to incubation with 294 
cells expressing the CCR5 coreceptor for 1 h at 37ºC.  After washing and lysis of the 295 
cells, bound gp120 was detected by immunoprecipitation.  As shown in Table 1 and 296 
Figure 4B, L478A was the only variant presenting reduced CCR5 binding to less than 297 
40%.  This defect was more pronounced upon sCD4 addition, suggesting that this 298 
mutant has some difficulties in assuming the CD4-bound conformation required to 299 
engage its co-receptor.  The defect in CCR5 binding could explain the lower cell-to-cell 300 
fusion efficiency brought by L478A (Figure 3B and Table 1).   However, its decreased 301 
subunit association, gp160 processing and CD4 binding could also account for this phenotype 302 
(Table 1). 303 
 304 
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DISCUSSION 305 
In the unliganded trimer, the gp120 must maintain its non-covalent association 306 
with gp41.  Layers 1 and 2 of the gp120 inner domain were recently shown to be 307 
important in maintaining the association of gp120 with the Env trimer in HIV but also SIV 308 
lineages (15, 17).  In HIV-1, Layer 3 was also shown to contribute to the association of 309 
gp120 with the unliganded Env trimer, likely through an indirect mechanism (16).  Here 310 
we extend these results to the SIV lineage since mutation of residues L478, Y479 and 311 
L481 to alanine resulted in a significant decrease in trimer stability.  These residues are 312 
located at the center of a hydrophobic interface between Layers 2 and 3 and in an 313 
analogue way to what was reported for W479 in HIV-1, where when mutated to an 314 
alanine (W479A) it results in a major shedding phenotype in R5-tropic Envs but to a 315 
lesser extent in R5X4 or X4 Envs,  (16), alteration of these residues might alter Layer 2-316 
Layer 3 interactions required for proper gp120-trimer association.  Shifts between the 317 
inner domain and outer domain that occur as a result of these changes in the Layer 2-318 
Layer 3 interface might affect the orientation of the variable regions which are known to 319 
affect trimer stability (36, 37). 320 
 321 
In the transition from the unliganded state to the CD4-bound state, the inner 322 
domain of gp120 experiences major conformational rearrangements (15, 38-42). 323 
Located at the interface between the inner domain and outer domain, Layer 3 has been 324 
shown to play a pivot-like role in the layered allosteric changes of the HIV-1 gp120 inner 325 
domain by decreasing the spontaneous sampling of the CD4-bound conformation, 326 
mainly through a decrease on-rate (16).  Analogous to the role played in HIV-1 we 327 
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found that SIVmac239 Layer 3 also played a critical role in securing CD4 binding mainly 328 
through an on-rate effect (Table 1).  Indeed, an on-rate decrease was observed for 329 
A476G, E477A, Y479A and E482A variants.  However, for other variants such as 330 
T248A, the decrease in CD4 binding was mediated by an accelerated off-rate (Table 1). 331 
Moreover, we found that in contrast to HIV-1 Layer 3, where only four residues 332 
contributed to CD4 binding (T248, H249, N478 and W479), eleven out of the thirteen 333 
residues mutated (with the exception of Q254A and A476G) dramatically affected CD4 334 
binding.  Decreased CD4 binding combined with defects in trimer stability likely explain 335 
the marked inability to mediate viral entry for the majority of SIVmac239 Layer 3 336 
variants. 337 
 338 
Altogether, our results show that subtle differences exist in the organization of 339 
the inner domain network of residues governing SIV and HIV-1 gp120 Layers 340 
interaction.  As summarized in Figure 6, the presence of a tryptophan at position 375, 341 
which fills the Phe 43 cavity, forces the gp120 to spontaneously sample the CD4-bound 342 
conformation in SIV lineages.  This differential arrangement of the inner domain Layers 343 
and the Phe43 cavity between HIV-1 and SIV gp120 glycoproteins might help explain 344 
why SIV envelope glycoproteins are generally less dependent on CD4 for CCR5 345 
interaction and able to infect cells that express low levels of CD4, and can maintain a 346 
long-lived sCD4-activated state (27, 43-48).  Since sampling the CD4-bound 347 
conformation might have unintended negative effects for the virus (decrease trimer 348 
stability, exposure of neutralizing epitopes (15-17, 19, 49)) this propensity is 349 
compensated by the strong contribution of Layer 1 to trimer stability.  Therefore, in SIV 350 
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gp120 tryptophan 375 and Layer 3 play a predominant role on CD4 interaction.  In HIV-351 
1 gp120, which lacks a tryptophan at position 375, the propensity to assume the CD4-352 
bound conformation is lower and therefore, Layers 1 and 2 help secure CD4 binding by 353 
decreasing the off-rate of gp120-CD4 interaction, as previously described (15).  354 
 355 
The major involvement of SIV gp120 Layer 3 in CD4 binding suggests that Layer 356 
3 residues are important for optimal exposure of the CD4-binding site. This is 357 
particularly true in SIV which has a large-filling residue at position 375 and where Layer 358 
3 appears to maintain a critical relationship between the gp120 inner and outer domains 359 
required for the intermolecular signaling required for gp41 HR1 exposure upon CD4 360 
interaction. Our work completes a detailed analysis of HIV and SIV inner domain layers 361 
and shows how subtle lineage-specific differences in the gp120 inner domain affect Env 362 
function.363 
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FIGURE LEGENDS 567 
 568 
Figure 1. Alignment and Structure of the inner domain of HIV-1 gp120 and 569 
modeled SIV gp120 in the CD4-bound conformation.  (A) The primary amino acid 570 
sequences of the gp120 inner domain Layer 3 and Phe 43 cavity of HIV-1 (accession 571 
number K03455), HIV-2 (accession number AAC95347.1) and SIVmac239 (accession 572 
number M33262) are aligned. Sequence identity is indicated by a solid vertical line. 573 
Gaps in the sequence are indicated by dashes.  Residue numbering is based on that of 574 
the HXBc2 strain of HIV-1 (31). (B) View of the conformation adopted by the inner 575 
domain Layers 1, 2 and 3 in the structure of the HIV-1HXBc2 gp120 core with N/C termini 576 
in the CD4-bound state (21) is shown. The outer domain (OD) of gp120 is colored 577 
yellow. The N and C termini are colored cyan.  The components of the gp120 inner 578 
domain (ID) are the β-sandwich (red) and three loop-like extensions:  Layer 1 579 
(magenta), Layer 2 (green) and Layer 3 (orange). (C) Same perspective than in B but 580 
using a modeled SIVmac239 gp120 glycoprotein, as described in Materials and 581 
Methods. (D) A close-up view of the interactions between HIV-1 Layer 2 and Layer 3. 582 
Critical Layer 3 residues that are between Layer 2 and Layer 3 are indicated. (E) A 583 
close-up view of the interactions between SIVmac239 Layer 2 and Layer 3. Critical 584 
residues of Layer 3 that are between Layer 2 and Layer 3 are indicated.          585 
 586 
Figure 2. Precursor processing and gp120-trimer association of SIVmac239 587 
envelope glycoprotein mutants.  Cell lysates and supernatants (SN) of 35S-labeled 588 
cells transiently expressing the SIVmac239 WT and mutant envelope glycoproteins 589 
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 30
were precipitated with serum from an SIV-infected macaque. The precipitates were 590 
washed, run on SDS-poly-acrylamide gels, and analyzed by densitometry. (A) The 591 
processing index is a measure of the conversion of the mutant gp160 envelope 592 
glycoprotein precursor to mature gp120 relative to that of the wild-type envelope 593 
glycoproteins. (B) The association index is a measure of the ability of the mutant gp120 594 
molecule to remain associated with the envelope glycoprotein complex on the 595 
expressing cell relative to that of the wild-type envelope glycoproteins. The processing 596 
index and association index were calculated as described in Materials and Methods. 597 
Data shown represent the average +/- standard deviation of at least four independent 598 
experiments.         599 
    600 
Figure 3. Functionality of SIV gp120 envelope glycoprotein variants.  (A) Relative 601 
infectivity was assessed on Cf2Th-CD4/CCR5 cells using RT-normalized amounts of 602 
pseudoviruses bearing SIV239 WT or Layer 3 variants. Data shown here is the ratio of 603 
mutant/wild-type virus infectivity. (B) Cell-to-cell fusion activity was assessed by co-604 
incubation between 293T cells expressing envelope glycoprotein variants and TZM-bl 605 
cells for 6 hours at 37℃. Luciferase activity in the mixture of cell lysate was measured 606 
and normalized to that mediated by WT envelope glycoprotein. Data shown represent 607 
the average +/- standard deviation of at least three independent experiments. 608 
 609 
Figure 4. Binding of soluble SIV gp120 glycoproteins to CD4-Ig and CCR5. 610 
Normalized amounts of radiolabeled wild-type and mutant gp120 glycoproteins were 611 
incubated with 2μg of CD4-Ig for 1 hour at 37ºC.  The precipitates were washed, run on 612 
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SDS-polyacrylamide gels, and analyzed by densitometry (A).  Representative results 613 
from at least three independent experiments are shown.  (B). Normalized amounts of 614 
radiolabeled gp120 glycoproteins were incubated in the absence (white bars) or 615 
presence (grey bars) of 200 nM sCD4 prior to addition to cells expressing CCR5.  After 616 
one hour at 37ºC, the amount of bound mutant gp120 was determined and normalized 617 
to the observed amount of bound wild-type (wt) gp120.  Incubation with sCD4 increased 618 
the binding of wt SIV gp120 to CCR5 by 7-fold.  The data shown represent the means 619 
+/- SEM of three independent experiments. 620 
 621 
Figure 5. Residues important for gp120-trimer association and CD4 binding.  622 
Layer 3 of HIV-1 gp120 (21) and the modeled SIVmac239 gp120 are shown from the 623 
same perspective as those in Figure 1, B and C.  In A, the ribbon and side chain 624 
residues that were altered in this and a previous study (16) are colored according to the 625 
gp120-trimer association index (Red: association index < 0.5 and Green: association 626 
index > 0.7).  In B, the ribbon and side chain residues are colored according to CD4-Ig 627 
binding ability (Red: relative CD4-Ig binding < 0.5 and Green: relative CD4-Ig binding > 628 
0.5).    629 
 630 
Figure 6. Summary of functional differences between HIV-1 and SIVmac239 gp120 631 
glycoproteins. One of the three gp120 subunits of the HIV-1 and SIVmac239 envelope 632 
glycoprotein trimer is depicted. In the orientation shown, the trimer axis runs vertically 633 
on the left of each figure and the viral membrane is at the top of the figure. The gp120 N 634 
and C termini are colored cyan, the β-sandwich red, Layer 1 purple, Layer 2 green, 635 
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Layer 3 yellow, and the outer domain (OD) ochre. The Trp 375 side chain that fills the 636 
Phe 43 cavity of SIV gp120 is depicted.  The major contributions of the gp120 N and C 637 
termini, the inner domain (the β-sandwich, Layer 1, Layer 2 and Layer 3) and the Phe 638 
43 cavity to gp120-trimer association and/or CD4 binding are shown.  Note that the 639 
contribution of the filled SIVmac239 gp120 Phe 43 cavity to CD4 binding is lacking in 640 
HIV-1 gp120; this lack is compensated by a contribution of the HIV-1 gp120 inner 641 
domain Layer 1 to CD4 binding, as reported (17). While Layer 3 is important for 642 
securing CD4 binding both in HIV-1 (16) and SIV gp120, the contribution appears to be 643 
more important in SIVmac239 gp120 due to the contribution of Layer 3 to maintain the 644 
integrity of the Phe 43 cavity.   645 
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